These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8730126)

  • 41. Cytosolic Ca2+ concentration determinations in neutrophils stimulated by monosodium urate and calcium pyrophosphate crystals: effect of protein adsorption.
    Burt HM; Jackson JK
    J Rheumatol; 1994 Jan; 21(1):138-44. PubMed ID: 8151569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
    Son E; Do H; Joo HM; Pyo S
    Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystals in vitro.
    Derfus B; Steinberg M; Mandel N; Buday M; Daft L; Ryan L
    J Rheumatol; 1995 Aug; 22(8):1514-9. PubMed ID: 7473476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggregation and inhibition of rat intestinal alkaline phosphatase by high concentrations of calcium. Reversibility of the processes.
    Brun LR; Traverso A; Rigalli A
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):691-6. PubMed ID: 18951287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of ascorbic acid, calcitriol, and retinoic acid on the differentiation of preosteoblasts.
    Choong PF; Martin TJ; Ng KW
    J Orthop Res; 1993 Sep; 11(5):638-47. PubMed ID: 8410463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
    Ryan LM; Wortmann RL; Karas B; Lynch MP; McCarty DJ
    J Clin Invest; 1986 May; 77(5):1689-93. PubMed ID: 3009553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium pyrophosphate crystal deposition in model systems.
    Mandel N; Mandel G
    Rheum Dis Clin North Am; 1988 Aug; 14(2):321-40. PubMed ID: 2845492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study.
    Cini R; Chindamo D; Catenaccio M; Lorenzini S; Selvi E; Nerucci F; Picchi MP; Berti G; Marcolongo R
    Ann Rheum Dis; 2001 Oct; 60(10):962-7. PubMed ID: 11557654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amino acid phosphatase activity of alkaline phosphatase. A possible role of protein phosphatase.
    Shinozaki T; Watanabe H; Arita S; Chigira M
    Eur J Biochem; 1995 Jan; 227(1-2):367-71. PubMed ID: 7851410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels.
    Hunter GK; Grynpas MD; Cheng PT; Pritzker KP
    Calcif Tissue Int; 1987 Sep; 41(3):164-70. PubMed ID: 2822212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps.
    Pang L; Hayes CP; Buac K; Yoo DG; Rada B
    J Immunol; 2013 Jun; 190(12):6488-500. PubMed ID: 23677474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.
    Fahey M; Mitton E; Muth E; Rosenthal AK
    J Rheumatol; 2009 Jan; 36(1):163-9. PubMed ID: 19132782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium crystal-associated arthritides.
    Rosenthal AK
    Curr Opin Rheumatol; 1998 May; 10(3):273-7. PubMed ID: 9608333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium pyrophosphate crystal deposition. An in vitro study using a gelatin matrix model.
    Mandel NS; Mandel GS; Carroll DJ; Halverson PB
    Arthritis Rheum; 1984 Jul; 27(7):789-96. PubMed ID: 6331461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
    Danino O; Svetitsky S; Kenigsberg S; Levin A; Journo S; Gold A; Drexler M; Snir N; Elkayam O; Fischer B; Arad U
    Rheumatology (Oxford); 2018 Aug; 57(8):1472-1480. PubMed ID: 29688536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.
    Caswell A; Guilland-Cumming DF; Hearn PR; McGuire MK; Russell RG
    Ann Rheum Dis; 1983 Aug; 42 Suppl 1(Suppl 1):27-37. PubMed ID: 6311118
    [No Abstract]   [Full Text] [Related]  

  • 57. Adenine-(methoxy)-ethoxy-P
    Nassir M; Mirza S; Arad U; Lee S; Rafehi M; Yaw Attah I; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
    Org Biomol Chem; 2019 Nov; 17(46):9913-9923. PubMed ID: 31720670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current advances in therapies for calcium pyrophosphate crystal arthritis.
    Sivera F; Andrés M; Pascual E
    Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of monoclinic calcium pyrophosphate dihydrate (m-CPPD) involved in inflammatory reactions and osteoarthritis.
    Gras P; Rey C; André G; Charvillat C; Sarda S; Combes C
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Feb; 72(Pt 1):96-101. PubMed ID: 26830800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of crystal induced neutrophil responses by opsonisation of calcium pyrophosphate dihydrate crystals.
    Burt HM; Jackson JK
    Ann Rheum Dis; 1993 Aug; 52(8):599-607. PubMed ID: 8215624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.